Neurocrine Biosciences, Inc. (NBIX) Posts Q3 EPS of $0.56, Revenues Rose 189% Y/Y
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $152.72 +1.26%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q3 EPS of $0.56, which may not compare to the analyst estimate of $0.19. Revenue for the quarter came in at $41.6 million versus the consensus estimate of $21.64 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Neurocrine Bio. (NBIX) PT Lowered to $182 at Morgan Stanley
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
